Cardiac Implants

US demand to reach $16.4 billion in 2012

US demand for cardiac implants will increase 8.8 percent annually to $16.4 billion in 2012. Evolving demographic and epidemiological patterns, along with the introduction of new and improved products, will promote growth. Based on aging population trends, the number of persons afflicted with one or more heart conditions is forecast to reach 73 million in 2012, up 1.7 percent per year from 2007. Implants are more effective than pharmaceuticals in treating, managing or preventing such cardiovascular disorders as arrhythmias, congestive heart failure, myocardial infarction, peripheral artery disease, stroke and valvular heart disease.

The market for cardiac implants is expected to recover from a sharp decline in coronary drug-eluting stent sales that began in mid-2006 and continued into the fourth quarter of 2007. This decline was due to a number of reports that linked the devices to a slightly greater risk of thrombosis in some post-angioplasty patients.

Although the reported risk was only onehalf of one percent greater than for heart patients who received alternative therapies (i.e., angioplasty with bare-metal stents, coronary bypass surgery, medications), it prompted many physicians to discontinue using drug-eluting stents.

This trend will change as new generation drug-eluting stents with smaller struts and a greatly reduced risk of complications reach the market over the next year.

ICDs, CRT devices will remain dominant types

Cardiac implants extend into several product groups. Implantable cardioverter defibrillators (ICDs) and related cardiac resynchronization therapy (CRT) devices together with their accessories generate the largest demand, followed by various types of stents. These two product groups will continue to lead cardiac implant sales based on new product introductions, widening eligibility for private and public health insurance coverage, expanding numbers of new patients, and diminishing safety concerns. Providing the most effective therapy for bradycardia, pacemakers and accessories will continue to serve a large, expanding US market.

However, growth opportunities for these devices will decelerate over the long term as they have already achieved a high level of market penetration.

Heart-related grafts will provide strong growth opportunities as improvements in stenting systems create new safe and effective devices for treating aortic aneurysms, peripheral arterial diseases and stroke. Demand for heart valves will benefit from advances in tissue engineering, which will improve the safety, performance and longevity of animalderived xenografts. Heart valve repair products, consisting of annuloplasty rings and bands, will also fare well in the marketplace as new cardiac diagnostics enable valvular heart diseases to be detected in earlier stages before complete valve replacement becomes necessary.

Less favorably, strong growth in the market for tissue valves and valve repair products will be partially offset by decreasing sales of mechanical valves.

Demand for embolic protection devices will rise at a strong pace as many more heart patients undergo procedures that pose an elevated risk of deep vein thrombosis and embolisms. The market for ventricular-assist devices will continue to grow moderately, spurred by widening applications in the management of pretransplant and late-stage heart conditions.

Based on their ability to detect heart attack symptoms earlier and save lives, implantable heart monitors will register strong sales growth over the long term.

Study coverage

Cardiac Implants is a new Freedonia industry study available for $4500. It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 for cardiac implant products by type and indication. The study also assesses evolving research and development, details company market shares and profiles 20 competitors in the US industry.

• Section Page
• Introduction Viii
• I. Executive Summary
• Ii. Market Environment
  • General
  • Macroeconomic Trends
  • Demographic Patterns
  • Health Insurance Trends
  • Medical Conditions
  • Acute Conditions
  • Chronic Conditions
  • National Health Expenditures
  • Medical Providers
  • Acute Care Hospitals
  • Outpatient Clinics
  • Skilled Nursing Homes
  • Physicians
  • Home Health Care Organizations
  • Patient Activity
  • Acute Care Hospital Admissions
  • Surgical Procedures
  • Outpatient Episodes
  • Home Health Care Visits
  • Medical Product Markets
• Iii. Cardiac Implant Overview
  • General
  • Cardiovascular Conditions
  • Coronary Heart Disease
  • Heart Rhythm Disorders
  • Peripheral Arterial Disease (Pad
  • Valvular Heart Disease
  • Stroke
  • Congestive Heart Failure (Chf
  • Congenital Heart Defects
  • Section Page
  • Cardiac Implant Procedures
  • Cardiac Implant Market Trends
  • Regulatory Factors
  • Demand Patterns
  • Product Groups
  • Indications
  • Us Trade
  • International Markets
• Iv. Pacing Devices
  • General
  • Demand Patterns & Projections
  • Producers & Market Share
  • Implantable Cardioverter Defibrillators (Icds
  • Technology
  • Components & Design
  • Functions
  • Clinical Data
  • Producers & Products
  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cardiac Resynchronization Therapy (Crt Devices
  • Technology
  • Producers & Products
  • Implantable Cardiac Pacemakers (Icps
  • Technology
  • Producers & Products
  • Medtronic
  • St. Jude Medical
  • Boston Scientific
  • Pacing Leads
  • Technology
  • Producers & Products
  • Pacemaker Leads
  • Icd Leads
  • Crt Leads
  • Pacing Device Batteries
  • Section Page
• V. Cardiac Stents & Related Implants
  • General
  • Demand Patterns & Projections
  • Producers & Market Share
  • Coronary Stents
  • Drug-Eluting Stents
  • Bare-Metal Stents
  • Peripheral Stents
  • Endovascular Stent-Grafts
  • Medtronic
  • Ancure
  • Other Endovascular Stent-Grafts
  • Renal & Related Stents
  • Femoral & Related Stents
  • Carotid Stents
  • Stent-Related Implants
  • Synthetic Grafts
  • Vascular Grafts
  • Peripheral Grafts
  • Vena Cava Filters
• Vi. Structural Cardiac Implants
  • General
  • Demand Patterns & Projections
  • Producers & Market Share
  • Heart Valves & Accessories
  • Product Overview
  • Tissue Heart Valves
  • Types Of Tissue Heart Valves
  • Producers & Products
  • Mechanical Heart Valves
  • Design
  • Producers & Products
  • Heart Valve Repair Products
  • Ventricular-Assist Devices
  • Technology
  • Producers & Products
  • Section Page
  • Implantable Heart Monitors
  • Insertable Loop Recorders (Ilrs
  • Implantable Hemodynamic Monitors
• Vii. Industry Structure
  • General
  • Market Share
  • Competitive Strategies
  • Mergers & Acquisitions
  • Licensing & Related Agreements
  • Research & Development
  • Marketing & Distribution
  • Manufacturing Activities
  • Company Profiles
  • Abbott Laboratories
  • Abiomed Incorporated
  • Angiotech Pharmaceuticals Incorporated
  • Arbor Surgical Technologies Incorporated
  • Bard (Cr Incorporated
  • Biophan Technologies Incorporated
  • Boston Scientific Corporation
  • Braun (B. Melsungen Ag
  • Carbomedics Incorporated, See Sorin Spa
  • Conor Medsystems Llc, See Johnson & Johnson
  • Cook Group Incorporated
  • Cordis Corporation, See Johnson & Johnson
  • Core Valve Incorporated
  • Edwards Lifesciences Corporation
  • Endologix Incorporated
  • Gore (Wl & Associates Incorporated
  • Johnson & Johnson
  • Medtronic Incorporated
  • Myotech Llc, See Biophan Technologies Incorporated
  • Sorin Spa
  • St. Jude Medical Incorporated
  • Terumo Corporation
  • Thoratec Corporation
  • Ventracor Limited
• List Of Tables
• Table Number Page
• Section I -- Executive Summary
  • Summary Table
• Section Ii -- Market Environment
  • 1 Macroeconomic Indicators
  • 2 Population By Age Group
  • 3 Health Insurance Coverage Of The Us Population
  • 4 Acute Conditions By Type
  • 5 Chronic Conditions By Type
  • 6 National Health Expenditures By Type & Source
  • 7 Medical Providers By Type
  • 8 Patient Activity By Type
  • 9 Medical Product Demand
• Section Iii -- Cardiac Implant Overview
  • 1 Cardiac Implant Market Indicators
  • 2 Cardiovascular Conditions By Type
  • 3 Cardiac Implant Procedures By Type
  • 4 Cardiac Implant Market, 1997-2007
  • 5 Cardiac Implant Demand By Product Group
  • 6 Cardiac Implant Demand By Indication
  • 7 Us Trade In Cardiac Implants
  • 8 World Cardiac Implant Demand By Region
• Section Iv -- Pacing Devices
  • 1 Pacing Device Demand By Product Group
  • 2 Implantable Cardioverter Defibrillator (Icd Demand By Type
  • 3 Cardiac Resynchronization Therapy (Crt Device Demand
  • 4 Implantable Cardiac Pacemaker Demand By Type
  • 5 Pacing Lead Demand By Type
• Section V -- Stents & Related Implants
  • 1 Cardiac Stent & Related Implant Demand By Product Group
  • 2 Coronary Stent Demand By Type
  • 3 Coronary Drug-Eluting Stent Demand
  • 4 Coronary Bare-Metal Stent Demand
  • 5 Peripheral Stent Demand By Product Group
  • 6 Endovascular Stent-Graft Demand
• List Of Tables
• Table Number Page
  • 7 Renal & Related Stent Demand
  • 8 Femoral & Related Stent Demand
  • 9 Carotid Stent Demand
  • 10 Stent-Related Implant Demand By Product Group
• Section Vi -- Structural Cardiac Implants
  • 1 Structural Cardiac Implant Demand By Product Group
  • 2 Heart Valve Implant Demand By Product Group
  • 3 Ventricular Assist Device Demand
  • 4 Implantable Heart Monitor Demand
• Section Vii -- Industry Structure
  • 1 Cardiac Implant Sales By Company, 2007
  • 2 Selected Acquisitions & Divestitures
  • 3 Selected Cooperative Agreements
• List Of Charts
  • Chart Number Page
• Section Iii -- Cardiac Implant Overview
  • 1 Cardiovascular Conditions By Type, 2007
  • 2 Cardiac Implant Procedures By Type, 2007
  • 3 Cardiac Implant Demand By Product Group, 2007
  • 4 Cardiac Implant Demand By Indication, 2007
• Section Iv -- Pacing Devices
  • 1 Pacing Device Demand By Product Group, 2007
  • 2 Pacing Devices Market Share By Company, 2007
• Section V -- Stents & Related Implants
  • 1 Stent & Stent-Related Implant Demand By Product Group,
  • 2007
  • 2 Stents & Stent-Related Implant Market Share By Company,
  • 2007
• Section Vi -- Structural Cardiac Implants
  • 1 Structural Cardiac Implant Demand By Product Group, 2007
  • 2 Structural Cardiac Implant Market Share By Company, 2007
• Section Vii -- Industry Structure
  • 1 Us Cardiac Implants, Market Share By Company, 2007
• Introduction
  • The Freedonia Group Is A Leading International Industry
  • Study/Database Company. Founded In 1985, Freedonia Now Publishes Over
  • 100 Studies Each Year Covering The Building Materials, Chemicals,
  • Communications, Health Care, Packaging, Pharmaceuticals, Plastics And
  • Security Industries, Among Many Others. Studies Cover Entire Industry
  • Sectors As Well As Key Niche Markets. Each Study Includes Such Valuable
  • Intelligence As Growth Markets And Products, Market Share, Product Analyses
  • And Forecasts, Market Analyses And Forecasts, And Company Profiles.
  • This Comprehensive Study Analyzes The Us Market For Cardiac
  • Implants. The Discussion Extends To Three Major Product Groups -- Pacing
  • Devices, Stents And Accessories, And Structural Cardiac Implants. Pacing
  • Devices Include Implantable Cardioverter Defibrillators (Icds And
  • Implantable Cardiac Pacemakers For The Management Of Heart Rhythm
  • Disorders As Well As Cardiac Resynchronization Therapy (Crt Devices For The
  • Management Of Congestive Heart Failure. Stents And Accessories Encompass A
  • Special Group Of Implants Which Serve Indications In The Treatment Of
  • Coronary And Peripheral Heart Disease. Structural Cardiac Implants Replace,
  • Repair, Supplement Or Monitor Weakened Or Damaged Components Of The
  • Heart. Included In This Group Are Heart Valves And Accessories, Ventricularassist
  • Devices And Implantable Loop Recorders (Ilrs.
  • Unless Otherwise Noted, The Historical Data And Forecasts Presented For
  • Cardiac Implants Represent Demand Stated In Current Dollars. The Term
  • demand Is Equivalent To value Of Consumption Or manufacturers Sales
  • And Equates To The Value Of Domestic Production Plus Imports Minus Exports.
• Introduction
  • Historical Data (1997, 2002, 2007 And Forecasts To 2012 And 2017 Are
  • Provided For Cardiac Implants By Product Type And Indication.
  • Corporate Information And Data Appearing In Section Vii, industry
  • Structure, Are Based Upon Estimates Derived From Published Company
  • Reports And Personal Interviews With Competitors, Industry Experts And
  • Sources Within The Companies Themselves. Macroeconomic Indicators Were
  • Taken From The Freedonia Group Consensus Forecasts Dated April 2008. The
  • Sum Of Individual Components Appearing In The Study Tables May Not Always
  • Add To The Apparent Total Due To Independent Rounding. All Ratios Were
  • Calculated On The Basis Of Unrounded Numbers.
  • Information And Data Related To The Us Cardiac Implant Market Were
  • Obtained From A Variety Of Primary And Secondary Sources Including
  • Government And Trade Associations, Industry Participants, Online Databases
  • And Other Freedonia Studies. Primary Information Was Gathered Through
  • Consultations With Officers And Marketing/Technical Personnel Of
  • Participating Companies And Other Industry Specialists.
  • Secondary And Background Information About Cardiac Implants Was
  • Derived From Publications Such As Biomedical Market Newsletter, Medical
  • Design Technology, Medical Device & Diagnostic Industry, Medical Plastics
  • And Biomaterials, And Medical Product Manufacturing News. Corporate
  • Annual Reports, Sec Form 10-K Filings, Product Catalogs And Other Company
  • Information Were Also Used Extensively In Framing The Industry Environment
  • And As Input For Market Size Assessments. Related Freedonia Studies Consulted
  • During The Preparation Of This Study Were #2255 Implantable Medical Devices
  • (10/07, #2196 Disposable Medical Supplies (05/07, #2168 Nanotechnology In
  • Health Care (2/07 And #2111 Biocompatible Materials (9/06.